NL-OMON46922
Completed
Not Applicable
A Post-Market, Prospective, Multi-Center, Single-Arm Clinical Investigation of Phasix Mesh for VHWG Grade 3 Midline Hernia Repair - Phasix mesh for the treatment of VHWG Grade 3 Midline Hernia Repair
Davol Inc.0 sites14 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- hernia cicatricalis
- Sponsor
- Davol Inc.
- Enrollment
- 14
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Trial is onging in other countries
Investigators
Eligibility Criteria
Inclusion Criteria
- •The subject must meet all of the criteria listed below to be enrolled in the study:
- •1\. Subject must be 18 years of age or older.
- •2\. Subject must be diagnosed with incisional midline hernia.
- •3\. Subject has a VHWG Grade 3 hernia (as defined in 5\.2\.3\).
- •4\. Size of hernia \* 10 cm2\.
- •5\. Subject must be willing to undergo a planned retro\-rectus hernia repair (onlay allowed as an exception when retro\-rectus placement cannot be achieved; using absorbable suture) with or without Component Separation Technique (CST).
- •6\. The subject is legally competent, has been informed of the nature, the scope and the relevance of the study, voluntarily agrees to participation and the study\*s provisions, and has duly signed the informed consent form (ICF). Subject agrees to comply with the protocol\-mandated procedures and visits.
Exclusion Criteria
- •The subject must be excluded from study enrollment if any of the following criteria are met:
- •1\. Subject with \> 4 previous repairs of the hernia under observation.
- •2\. Body Mass Index (BMI) \> 35 kg/m2\.
- •3\. The subject is on, or suspected to be placed on, chemotherapy medications during any part of the study.
- •4\. The subject has peritonitis.
- •5\. Known human immunodeficiency virus (HIV) infection (if documented in the subject\*s record).
- •6\. The subject has cirrhosis of the liver and/or ascites.
- •7\. Subject is American Society of Anesthesiology Class 4 or 5\.
- •8\. Complete removal of existing mesh from a prior hernia repair (in the same affected area) is not possible.
- •9\. The hernia repair requires more than a single piece mesh (with adequate overlap beyond the margins of the defect on all sides).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A Prospective, Multicenter, Open Label, Single Arm, Study to Assess the Safety & Performance of the Harmony Aortic Stimulation System (HASS) for the Treatment of Heart FailureCardiac FailureHeart Failure10019280NL-OMON51726van de Wetering CRC2
Completed
Phase 4
A Multi Center, Prospective, Observational, Open-label, Pharmacokinetic Study of Tacrolimus in Heart and Lung Transplantation Patients during the First Days after TransplantatioHeart and lung transplantation100192801003868610038716NL-OMON39373niversitair Medisch Centrum Utrecht30
Completed
Phase 2
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS) [DELIVERS Study]NL-OMON47706Castle Creek Pharmaceuticals, LLC4
Recruiting
Phase 2
An Open- Label, Phase 2, Multicenter Feasibility Study if Manualized MDMA-Assisted Psychotherapy with an fMRI sub-study Assessing Changes in Brain Activity in Subjects with Post-Traumatic Stress DisorderNL-OMON56347MAPS Europe B.V.8
Completed
Phase 3
A Multicenter Randomized Controlled Trial to Compare the Efficacy of End-ischemic Dual Hypothermic Oxygenated Perfusion with Standard Static Cold Storage of Liver Grafts Donated after Circulatory Death in Preventing Non-anastomotic Biliary Strictures after TransplantatioEnd-stage liver disease100179431001965410019818NL-OMON47263niversitair Medisch Centrum Groningen120